PIN1 and acute promyelocytic leukemia: As an alternative, we tested all-trans retinoic acid (ATRA), an agonist of the retinoic acid receptor (RAR) that is used medically to treat acute promyelocytic leukemia (APL) and was recently reported to inactivate Pin1 isomerase activity20.